Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

NCT00520741 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
426
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB BIOSCIENCES, Inc.